PMID- 26365696 OWN - NLM STAT- MEDLINE DCOM- 20161024 LR - 20191210 IS - 1873-2933 (Electronic) IS - 0009-9120 (Print) IS - 0009-9120 (Linking) VI - 49 IP - 1-2 DP - 2016 Jan TI - Development and validation of an immunosensor for monocyte chemotactic protein 1 using a silicon photonic microring resonator biosensing platform. PG - 121-6 LID - S0009-9120(15)00431-2 [pii] LID - 10.1016/j.clinbiochem.2015.09.001 [doi] AB - OBJECTIVES: We report the development of an optical immunosensor for the detection of monocyte chemotactic protein 1 (MCP-1) in serum samples. MCP-1 is a cytokine that is an emerging biomarker for several diseases/disorders, including ischemic cardiomyopathy, fibromyalgia, and some cancers. DESIGN AND METHODS: The detection of MCP-1 was achieved by performing a sandwich immunoassay on a silicon photonic microring resonator sensor platform. The resonance wavelengths supported by microring sensors are responsive to local changes in the environment accompanying biomarker binding. This technology offers a modularly multiplexable approach to detecting analyte localization in an antibody-antigen complex at the sensor surface. RESULTS: The immunosensor allowed the rapid detection of MCP-1 in buffer and spiked human serum samples. An almost 2 order of magnitude linear range was observed, between 84.3 and 1582.1pg/mL and the limits of blank and detection were determined to be 0.3 and 0.5pg/mL, respectively. The platform's ability to analyze MCP-1 concentrations across a clinically-relevant concentration range was demonstrated. CONCLUSIONS: A silicon photonic immunosensor technology was applied to the detection of clinically-relevant concentrations of MCP-1. The performance of the sensor was validated through a broad dynamic range and across a number of suggested clinical cut-off values. Importantly, the intrinsic scalability and rapidity of the technology makes it readily amenable to the simultaneous detection of multiplexed biomarker panels, which is particularly needed for the clinical realization of inflammatory diagnostics. CI - Copyright (c) 2015 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved. FAU - Valera, Enrique AU - Valera E AD - Department of Chemistry, University of Illinois at Urbana - Champaign, 600 South Matthews Avenue, Urbana, IL 61801, United States. FAU - Shia, Winnie W AU - Shia WW AD - Department of Chemistry, University of Illinois at Urbana - Champaign, 600 South Matthews Avenue, Urbana, IL 61801, United States. FAU - Bailey, Ryan C AU - Bailey RC AD - Department of Chemistry, University of Illinois at Urbana - Champaign, 600 South Matthews Avenue, Urbana, IL 61801, United States. Electronic address: baileyrc@illinois.edu. LA - eng GR - R33 CA177462/CA/NCI NIH HHS/United States GR - R33-CA177462-01/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PT - Validation Study DEP - 20150910 PL - United States TA - Clin Biochem JT - Clinical biochemistry JID - 0133660 RN - 0 (Biomarkers) RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) SB - IM MH - Biomarkers/*blood MH - *Biosensing Techniques MH - Chemokine CCL2/*blood MH - Fibromyalgia/blood/diagnosis MH - Humans MH - Limit of Detection MH - Myocardial Ischemia/blood/diagnosis MH - Neoplasms/blood/diagnosis MH - Photons PMC - PMC4715927 MID - NIHMS726161 OTO - NOTNLM OT - Cytokine OT - Diagnostic OT - Immunoassay OT - Optical biosensor OT - Silicon photonics EDAT- 2015/09/15 06:00 MHDA- 2016/10/25 06:00 PMCR- 2017/01/01 CRDT- 2015/09/15 06:00 PHST- 2015/06/06 00:00 [received] PHST- 2015/09/03 00:00 [revised] PHST- 2015/09/06 00:00 [accepted] PHST- 2015/09/15 06:00 [entrez] PHST- 2015/09/15 06:00 [pubmed] PHST- 2016/10/25 06:00 [medline] PHST- 2017/01/01 00:00 [pmc-release] AID - S0009-9120(15)00431-2 [pii] AID - 10.1016/j.clinbiochem.2015.09.001 [doi] PST - ppublish SO - Clin Biochem. 2016 Jan;49(1-2):121-6. doi: 10.1016/j.clinbiochem.2015.09.001. Epub 2015 Sep 10.